Company Overview and News
New Delhi: In a letter addressed to the resolution professional (RP) and the committee of creditors (CoC) conducting the auction of Essar Steel to recover over ₹49,000 crore of unpaid loans to banks, VTB Capital-backed Numetal on Monday questioned the eligibility of ArcelorMittal . This comes at a time when the matter is to be heard by the Supreme Court on Tuesday.
AMSYF MTCN 513142 MT 500228 BALASORE 513216 MT VEDL JSWSTEEL UTTAMSTL
When considering valuation metrics, price-to-earnings ratio has always been the obvious choice as calculations based on earnings are easy and come in handy. However, price-to-sales has emerged as a convenient tool to determine the value of stocks that are incurring losses or are in an early cycle of development, generating meager or no profits. While a loss-making company with a negative price-to-earnings ratio falls out of investor favor, its price-to-sales could indicate the hidden strength of its business.
CVG MT GTS MT INT UNFI RCKY
On Sep 13, European Central Bank (ECB) President Mario Draghi reaffirmed that the central bank of 19-member Eurozone will continue its accommodative monetary policy, keeping all three benchmark interest rates unchanged. Moreover, the central bank has opted for a phased elimination of its ongoing monthly bond purchase program by the end of this year. Per the ECB, continuing economic expansion and a rising wage rate will absorb growing inflation in Eurozone.
MT CY GLOB MT
ArcelorMittal (MT - Free Report) has submitted a revised proposal for the acquisition of Essar Steel India Limited to the latter’s Committee of Creditors. The offer also includes a commitment to pay the total amount due to the financial creditors of KSS Petron and Uttam Galva. As such, it represents unprecedented value to all concerned creditors. According to a report by Reuters, ArcelorMittal raised the bid to 420 billion rupees (or roughly $5.
HUN MT NGVT LB MT NGVT.WI CE
American steel mills operated above 80% of their capacity last week, according to the latest weekly report from the American Iron and Steel Institute (AISI), an association of North American steel makers. Capacity utilization rate – a key metric in the steel industry – reached 80.2% for the week ending Sep 8, up from 73.4% a year ago, according to data released by the AISI. The feat appears to reflect the impact of broad-based tariffs which the Trump administration imposed on imported steel under Section 232 of the Trade Expansion Act of 1962.
MT STLD MT NUE USAP
ArcelorMittal (MT - Free Report) has reached a provisional labor agreement with Ilva’s trade unions. The move marks a progress in AM Investco Italy Srl’s planned buyout of Ilva S.p.A. One of the key terms of the agreement provides a solution for Ilva’s existing workforce. ArcelorMittal also committed to hire 10,700 workers initially on the basis of their contractual terms of employment. Moreover, the company, between 2023 and 2025, will hire any worker under Ilva’s administration.
HUN WU MT NGVT MT FIVE NGVT.WI CE
2018-09-05 zacks - 1
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
MT HDS MT
ArcelorMittal’s (MT - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Let’s take a look into the factors that make this steel giant an attractive investment option. What’s Working in Favor of MT? Solid Rank & VGM Score: ArcelorMittal currently has a Zacks Rank #2 (Buy) and a VGM Score of A.
HUN MT NGVT MT NGVT.WI CE
Chicago, IL – August 17, 2018 - Stocks in this week’s article are Dollar Tree Inc. (DLTR - Free Report) , Agenus Inc. (AGEN - Free Report) , Huntsman Corp. (HUN - Free Report) , ArcelorMittal (MT - Free Report) and International Paper Co. (IP - Free Report) .
HD AGEN INPAP FCCTO BGSF FCCTP DLTR FCCO HUN IP MT HEAR OXY MT FIVE FCCT
2018-08-16 zacks - 1
Bargain hunting or looking for stocks with a low price-to-earnings (P/E) ratio is among the widely-used investing strategies. Investors believe that the lower the P/E, the higher will be the value of the stock. The logic is simple — a stock’s current market price does not justify its higher earnings and therefore leaves room for upside.
DLTR HUN IP MT AGEN INPAP MT
ArcelorMittal’s (MT - Free Report) profits rose in second-quarter 2018, supported by a spike in steel prices. The company recorded net income of $1,865 million or $1.83 per share, up from $1,322 million or $1.29 in the year-ago quarter. Revenues went up roughly 16% year over year to $19,998 million in the quarter on the back of higher average steel selling prices, market-priced iron ore shipments, seaborne iron ore reference prices and steel shipments.
MT KMG NGVT MT NGVT.WI CE
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to EPA:MT / ARCELORMITTAL on message board site Silicon Investor.